Permit + premises timing
Finish the facility against a checklist, confirm permitted use and required inspections, and keep research/production separate from retail stock. Do not assume the planned November completion has occurred until verified.
Internal working plan · As of 20 October 2026
2027 is a year to stabilize cash, prove GolBi, and earn the right to scale.
PHYTOSPHERE has a strong mission and a credible innovation story. But the business reality is that GolBi is still in technical validation, permits are in progress, the facility is being finished, and unrestricted operating capital is tight. The plan must secure near-term revenue without risking grant compliance or prematurely scaling an unready product.
Planning principle: sell services and compliant products where possible; validate before product commercialization; defer capital-heavy R&D until funded.
One mission. Three different roles.FOCUS · PROOF · CASH
TerraSyncEarn near-term service revenue
PAGBITurn compliant stock into cash carefully
GolBiUse grant-funded validation to reduce risk
Microbial R&DPause until a separate budget exists
GolBi
TRL 4 · Not market-readyTechnical validation is the priority; do not forecast commercial GolBi revenue yet.Facility
30 m² planned18 m² research/production + 12 m² agrivet; completion before Nov 2026 is a target to verify.Compliance
Local + FPA steps pendingMayor’s permit not ready; dealer/repacker licensing in progress. Confirm product-specific requirements separately.Capital
Restricted funds ≠ cash runwayNo additional operating budget reported. Ring-fence grant funds and inventory money.Start with the truth
The immediate problem is not lack of ideas. It is the gap between ideas and cash-generating, compliant operations.
Use the next 12 months to lower the cost of uncertainty. Don’t build all product lines at once. Give each business unit a clear job and a spending gate.
Commercialization gate
GolBi is not ready for commercial sale. FPA paperwork for dealer/repacker activities does not automatically mean GolBi itself is cleared for sale. Confirm applicable product registration or experimental-use pathway with FPA before sales, repacking, promotional claims or distribution.
GolBi is not ready for commercial sale. FPA paperwork for dealer/repacker activities does not automatically mean GolBi itself is cleared for sale. Confirm applicable product registration or experimental-use pathway with FPA before sales, repacking, promotional claims or distribution.
Cash discipline gate
The approximately ₱88,000 arithmetic balance from the DOST-TAPI grant is not unrestricted cash. It is ₱158,000 awarded minus approximately ₱70,000 used, before outstanding commitments and reconciliation. Spend only on approved project items under the signed grant agreement.
The approximately ₱88,000 arithmetic balance from the DOST-TAPI grant is not unrestricted cash. It is ₱158,000 awarded minus approximately ₱70,000 used, before outstanding commitments and reconciliation. Spend only on approved project items under the signed grant agreement.
Too many projects
GolBi, microbial agents, new botanical sources, TerraSync, Agrinexa and PAGBI cannot all receive equal capital and attention. Prioritize work that either earns cash soon or fulfills funded validation obligations.
Unproven economics
Do not infer profit from sales or a large proposed stock budget. Calculate contribution margin after purchase cost, freight, discounts, fees, spoilage/expiry and labor before buying or pricing.
Confidential adviser assessment
Red flags to fix—and assets to exploit.
This is an internal diagnosis, not public-facing marketing copy. Treat risks as decisions with deadlines and consequences.
1. No commercial GolBi revenue yet
GolBi is still in technical validation; the local business permit, FPA dealer/repacker path and facility readiness remain incomplete. Product validation is not sales authorization.
Required action: freeze commercial sales claims and unapproved selling/repacking. Obtain written confirmation of the exact regulatory path and evidence milestones.
2. Grant spend is not yet reconciled
Approximately ₱70,000 of the ₱158,000 DOST-TAPI award has reportedly been used. The ₱88,000 difference is only arithmetic—not free cash—until receipts, commitments and grant budget lines are reconciled.
Required action: match every expense to approved grant lines before the next procurement; document variances with the project officer.
3. Too many bets for current capital
GolBi, muscardines, new botanical sources, Agrinexa, TerraSync and PAGBI cannot all receive equal capital and founder time while cash is tight.
Required action: TerraSync = near-term cash; PAGBI = controlled retail pilot after authorization; GolBi = funded validation; microbial and new botanical development = pause unless separately funded.
4. TerraSync is the fastest low-capital test
Use existing web, app and automation skills to sell fixed-scope websites, maintenance, order workflows and small software implementation projects. Do not build more features before selling a paid project.
Required action: sell 3 clear offers; request deposits; measure hours, revisions, delivery time and contribution per project.
5. PAGBI can monetize local demand—but only with discipline
The ₱120,000 inventory envelope is not a reason to spend ₱120,000 immediately. Price-sensitive growers, input-price movement and expired stock can convert cash into dead inventory.
Required action: verify permits, obtain current supplier quotes, start with a small pilot lot, and replenish only after measured sell-through and positive margin.
6. DOST-TAPI and awards create credibility, not proof of demand
Use the grant to produce credible validation outputs and use award recognition to open doors to labs, institutions, funders and cooperatives—not as a substitute for independent testing or repeat purchases.
Required action: build a milestone-backed evidence pack with costs, methods, results, limitations and next funding need.
Hard rule: no microbial machines, new extraction equipment, large inventory reload, paid advertising campaign or new recurring software subscription until the project has an identified funding source and the 13-week cash forecast still covers committed obligations.
Market watch · 20 October 2026
Price and demand assumptions must be refreshed—not guessed.
Use public indicators as warning signals, but use current supplier quotations and actual customer buying behavior for purchasing decisions.
Required market-intelligence routine: before each PAGBI purchase, collect current quotes from up to 3 suppliers for important SKUs; record landed unit cost, freight, credit terms, expiry, expected days-to-sell and minimum margin. Reconfirm quotes older than 7 days. Review high-turn and slow-moving stock every week. The 7-day rule is a management control, not a market rule.
Sources: PSA Region XI, September 2026; Philippine Statistics Authority national CPI; FPA weekly pesticide and fertilizer prices.
Who we are
Vision, mission, and the four values that guide every decision.
To become Mindanao’s leading agricultural biotechnology inputs enterprise, advancing scalable, science-driven, and sustainable crop protection solutions for Filipino farmers.
To serve farmers with holistic and SMART crop protection inputs through sustainable biotechnology, research-driven innovation, and resource-efficient solutions that improve agricultural productivity and strengthen farming communities.
01
Innovative
Recognize opportunities and turn agricultural challenges into practical, science-based solutions.
02
Sustainability-Centered
Make long-term farm productivity, environmental responsibility, and resource conservation part of every decision.
03
Farmer-Centeredness
Create measurable value by solving farmers’ real problems at a price and service level they can use.
04
Resourcefulness
Use existing capital, skills, local resources, digital capabilities, and partnerships before buying more capacity.
Portfolio focus
Give each enterprise a different job in 2027.
Do not rely on an unapproved product to pay today’s bills. Build bridge revenue while the biotechnology work is validated and documented.
Priority 1 · Cash engine01
TerraSync — software and digital services
Use existing skills to sell defined, low-capital services before investing in a broader software platform.
- Website and landing-page builds for local SMEs, farms, agrivets and organizations.
- Website maintenance, product catalogues, order forms and lightweight inventory/order workflows.
- Agrinexa remains a beta/pilot until usage, willingness to pay and retention are proven.
Cash rule: quote in writing, scope clearly, collect a deposit (proposed baseline: 50%) before work, and bill milestones promptly.
Priority 2 · Conditional trade02
PAGBI Agrivet Supplies — small, fast-turning stock
Agrivet retail could generate nearer-term transactions, but inventory ties up cash and product sales depend on correct permits and compliant stock.
- Start with a narrow list of products supported by customer requests and supplier quotes.
- Compare at least 3 current supplier quotes for material items; monitor price, availability and expiry.
- Separate PAGBI books, inventory, cash and payables from PHYTOSPHERE’s research project.
Cash rule: no bulk buy until applicable local/FPA authorizations are in place and SKU-level contribution margin is calculated.
Priority 3 · Funded proof03
GolBi — technical validation, not sales forecasting
Keep the flagship product as the strategic asset, but make its next milestone evidence, consistency, documentation and compliance—not commercial volume.
- Reconcile and protect DOST-TAPI funds; follow the approved project work plan and procurement rules.
- Complete grant-supported tests, maintain batch records and define acceptance criteria.
- Confirm the separate product-registration/authorization path and commercialization gates with FPA.
Gate to advance: documented technical evidence + consistent batches + regulatory clearance + viable unit economics.
Priority 4 · Defer unfunded work04
Microbial facility and other botanicals
Muscardine upgrades need machines/equipment that are not funded. Citronella and other botanical sources broaden the research workload before the lead product is ready.
- Freeze machine purchases and expansion of microbial production until separate funding or an institutional partner is secured.
- Keep new botanical sources at desk-research or very small, separately funded screening stage.
- Reopen these projects only after core GolBi milestones and cash/runway conditions are met.
Cash rule: no unbudgeted capex, no diverting TAPI grant funds, no parallel R&D program without a funded work plan.
Scale-readiness re-check
The reality-based score is lower—and more useful—than an optimistic growth score.
This is a provisional management estimate from the October 2026 facts you supplied, not an audited rating. Re-score when permits, revenue and test results are evidenced.
Strategy & Market Position
10/20Value proposition is clear, but product-market fit and repeatable revenue are not proven.
Operations & Infrastructure
10/20Supply capacity is weak; processes and batch controls still need to be proven.
Team, Leadership & Culture
8/20Key-person dependence and thin leadership coverage constrain parallel workstreams.
Financial Health & Capital
6/20Business is in the red; unit economics and unrestricted runway are not yet evidenced.
42.5%
Adviser re-rating: 34/80 (42.5%)
A conservative internal estimate based on the facts provided—not an audited or third-party score. Priority is to prove demand, cash generation, and compliant delivery before scaling.
Method: Strategy 10/20; Operations 10/20; Organization 8/20; Financial Health 6/20. The original worksheet scores do not reconcile: the listed item values sum to 45 across 75 available points, not 43/80. Re-score quarterly using evidence, and have management confirm the ratings.
SWOT + root causes
Strong ambition and grant support—but cash, permissions and repeatable delivery are the bottlenecks.
Use the SWOT to choose what to do now, what to defer, and what needs outside help. It is an operating diagnosis, not a marketing claim.
S Strengths · inside the business
- Recognized PHYTOSPHERE brand and award history.
- DOST-TAPI support earmarked for GolBi technical validation.
- Founder has product-development, agriculture, and digital-service capabilities.
- Planned 30 m² location with research/production and retail zones.
- TerraSync and PAGBI create routes to earn revenue not dependent on GolBi launch.
Use it: convert existing recognition and skills into customer meetings, paid service jobs and credible validation outputs.
W Weaknesses · inside the business
- GolBi is not yet ready for commercialization; permits are incomplete.
- Building completion, quality systems, supplier capacity and regulatory path remain in progress.
- No additional operating budget; business is described as “in the red.”
- About ₱70,000 of the TAPI grant has been used and needs transaction-level reconciliation.
- Microbial equipment is absent; repeat purchase, product economics and steady revenue are unproven.
Root cause: several product and business directions are competing for a small amount of cash, time and operating capacity.
O Opportunities · outside the business
- Sell TerraSync digital work in small, deposit-funded projects.
- Open PAGBI to local growers with a narrow assortment after required permits are confirmed.
- Collaborate with qualified laboratories, universities, cooperatives and agricultural groups.
- Use AI-assisted records and website/order tools to reduce admin friction.
- Position GolBi’s next funding ask around completed validation milestones and a clear cost model.
Best fit now: low-capital services plus carefully controlled retail can bridge the business while the biotech asset is validated.
T Threats · outside the business
- Regulatory delays can postpone product sales even if a facility is ready.
- Established agrivet brands and price-sensitive growers can compress margins.
- Crop cycles, weather and seasonal raw materials can change demand and availability.
- Fuel/inflation pressure can change freight, input replacement costs and customer spending.
- Grant or compliance errors could damage project delivery, partner confidence and funding prospects.
Response: reprice using current quotes, hold smaller stock lots, document compliance, monitor cash weekly and build contingencies.
Market and price volatility
Plan around changing conditions, not a fixed forecast.
Recent official indicators show that agricultural output and business sentiment can move in either direction. They do not prove demand for PHYTOSPHERE’s own products; they support active monitoring.
−2.6%
Davao de Oro vegetable production · 2025
PSA reported vegetable production at 30,350.1 MT in 2025, down 2.6% from 2024. This can affect crop mix, growing cycles and input purchasing patterns.
PSA regional data ↗−0.2%
Davao Region vegetable/root crop volume · Q1 2026
Q1 production was 27,994.36 MT versus 28,037.23 MT in Q1 2025. Small regional changes can hide large crop-by-crop differences.
PSA Q1 situationer ↗Risk-aware
Business confidence and input costs
BSP reported that business confidence turned pessimistic in July 2026 amid oil-price and inflation concerns. Treat supplier prices, freight and customers’ purchasing power as moving variables.
BSP survey release ↗Weekly market-check routine
For PAGBI, obtain fresh quotes from at least 3 suppliers for core items; compare delivered cost against competitor prices and expected selling price; recalculate margin after freight, discounts, expiry/spoilage and payment fees. Review the FPA weekly price archive plus current supplier offers. For TerraSync, log lead source, quote acceptance, time spent, deposits, project profit and repeat requests monthly.
For PAGBI, obtain fresh quotes from at least 3 suppliers for core items; compare delivered cost against competitor prices and expected selling price; recalculate margin after freight, discounts, expiry/spoilage and payment fees. Review the FPA weekly price archive plus current supplier offers. For TerraSync, log lead source, quote acceptance, time spent, deposits, project profit and repeat requests monthly.
Financial control tower
Protect restricted funds. Separate the cash engines. Freeze unfunded expansion.
These are planning controls built from the numbers you supplied. Reconcile amounts against bank statements, receipts, unpaid commitments and grant terms before making a purchase.
₱158,000
Total grant reported for GolBi technical validation. Reported usage is approximately ₱70,000.
Arithmetic balance: approximately ₱88,000 before outstanding commitments, actual disbursement reconciliation and any project-specific conditions. This is not unrestricted cash and must not be redirected to inventory, payroll or unrelated bills without written authorization.
₱120,000 + ₱6,000?
You described a ₱120,000 stock budget and ₱6,000 for FPA registration. Confirm whether the ₱6,000 is included in the ₱120,000 envelope or is additional.
Decision before commitment: record a separate approved amount for licensing and stock. If ₱6,000 is inside ₱120,000, a maximum ₱114,000 remains for inventory before other costs; if outside, the combined planned commitment is ₱126,000. Do not assume the money is currently free cash or spend it before the relevant authorizations and supplier economics are checked.
1. Weekly 13-week cash forecast
List opening bank/cash, confirmed collections, payroll/owner draws, supplier payables, utilities, fees, grant commitments and closing cash week by week. Separate restricted, inventory and unrestricted balances.
2. Monthly close by the 5th working day
Reconcile receipts, invoices, bank balances, stock, receivables and payables. Prepare simple profit-and-loss reports by TerraSync, PAGBI and PHYTOSPHERE R&D.
3. Purchase-order gate
No new inventory, equipment or subscriptions unless its source of cash is identified, a current quote is available, expected cash conversion is clear, and the 13-week forecast remains viable.
Important distinction: dealer/repacker licensing, the permit to operate the business, and the product’s own authorization are distinct compliance questions. FPA provides separate application forms for product registration, experimental-use permits, dealerships and repackers. Confirm the route that applies to each activity and product with FPA before sales or repacking.
V. Action Plan · Template-aligned
The actual operating plan: activities, dates, spending gates, partners and resources.
Use this as the internal working table. Amounts are conservative decision ceilings, not proof that cash is available. Reconcile and secure approvals before committing any funds.
Full action-plan table. On a smaller screen, scroll horizontally. Use the quarter filter above to isolate what needs to happen. Budget figures are ceilings or provisional planning buckets—not permission to spend.
| Focus Areas | Strategies | Activities | Timeline | Budget Allocation | Potential Partners / Enablers | Resources Needed |
|---|---|---|---|---|---|---|
| 1. Market Penetration / Expansion TerraSync · cash engine | Monetize existing digital skills before making new product investments. | Q4 2026: Package 3 fixed-scope offers (website launch/fix, maintenance, farm/retail order workflow). Prepare portfolio, price floor, proposal and contract. Q1: Contact 10 qualified prospects per month; aim for 2 paid pilot jobs with written scope and advance deposit. Q2: Publish 2 case studies; test maintenance/hosting or workflow support retainers. Q3: Prioritize referrals and repeat clients; stop low-margin custom work. Q4: Scale only the offers with positive contribution and timely collection. | Start now; weekly prospecting; monthly review; Q1–Q4 2027. | ₱0 paid ads. Up to ₱3,000 one-time outreach/delivery allowance only from deposits or collected client cash. No new subscription/tool purchase until paid work funds it. | Local SMEs, farm input retailers, cooperatives, agriculture groups, school/community networks and client referrals (potential; not confirmed partners). | Portfolio, three service packages, pricing calculator, lead tracker, quote/contract templates, deposit invoice, delivery checklist and time log. |
| 1. Market Penetration / Expansion PAGBI · staged retail | Turn local demand into sales without locking the entire cash envelope in slow-moving stock. | Q4 2026: Confirm mayor’s permit, FPA dealer/repacker applicability, facility requirements and supplier terms before opening or handling regulated products. Q1: Interview 10–15 local growers/retail buyers; prepare 3-supplier quote sheet for high-demand SKUs. Q2: After approvals, run a controlled first purchase; prioritize proven fast-moving products with valid registrations and documented margins. Q3: Review sell-through, margin, stock age and customer reorders every month. Q4: Replenish only proven SKUs; remove slow movers from reorders. | Permit gate first; then a 60–90 day pilot; monthly review. | Planning envelope: ₱120,000 stock budget + ₱6,000 registration reserve (verify if separate or included). Adviser gate: first inventory tranche ≤₱30,000; hold the rest until sell-through is proven. If ₱6,000 is inside ₱120,000, inventory ceiling becomes ₱114,000. | FPA, LGU permitting offices, legitimate registered suppliers, local growers, cooperatives and agrivet customers (potential). | Written licensing status, supplier invoices/quotes, registered-product verification, expiry/lot logs, shelf/storage plan, SKU margin sheet, sales and receivables ledger. |
| 1. Market Penetration / Expansion GolBi · evidence before sales | Build product and market evidence; do not treat technical validation as commercial clearance. | Q4 2026: Confirm applicable product authorization path and align claims to approved protocols. Q1: Identify target pest/crop/use case and independent validation evidence required. Q2: Collect structured observations from permitted validation activity; record results, limitations and farmer feedback. Q3: Prepare a data-backed product brief and next-stage funding case. Q4: Decide go / repeat test / pause based on evidence and regulatory status. | Quarterly gates; no commercialization date assumed. | ₱0 marketing budget in base case. Technical activity funded only from reconciled, uncommitted and grant-eligible TAPI lines. No sales revenue assumed in 2027 base plan. | DOST-TAPI project officer, qualified testing laboratories, agricultural researchers, validation farms and FPA (approvals/status must be verified). | Approved test protocol, field log, batch identifiers, chain-of-custody/records as applicable, costed evidence package and written regulatory guidance. |
| 2. Operational Efficiency & Productivity Facility + compliance | Finish and operate the existing 30 m² facility safely before adding capacity. | Q4 2026: Complete an itemized punch list for the planned November building completion; document the 18 m² research/production area and 12 m² agrivet area, ventilation, separation, storage, fire/safety, utilities and inspection requirements. Q1: Verify actual completion, permitted use and required inspections; resolve gaps before regulated activity. | Cost-to-complete and punch list now; completion target before Nov 2026; verification in Q1. | Not budgeted until quoted. Obtain contractor cost-to-complete and identify a lawful, unrestricted source. Do not charge construction to DOST-TAPI unless the signed grant budget expressly permits it. | Building contractor, LGU, FPA as applicable, fire/safety or other required inspectors, project officer. | Signed quote, scope/punch list, photos, receipts, inspection records, layout and storage/segregation plan. |
| 2. Operational Efficiency & Productivity GolBi quality system | Use the grant to close its promised validation milestones and create a repeatable record—not to subsidize general operations. | Q4 2026: Reconcile the ₱158,000 award, ~₱70,000 reportedly used, invoices, commitments and approved budget lines before next procurement. Q1: Confirm tests, methods, success criteria, materials and delivery dates with the project officer/lab. Q2: Execute approved efficacy, phytotoxicity, stability or other required tests as stated in the grant plan. Q3: Repeat batches or testing only where protocol and budget allow; record deviations and corrective action. Q4: Complete report/evidence archive and agree next technical gate. | Reconciliation before further grant procurement; Q1–Q4 milestones per approved work plan. | ₱88,000 nominal arithmetic difference only. Provisional planning buckets for review: testing/analysis up to ₱35,000; approved test materials/reagents up to ₱22,000; validation-batch consumables/packaging up to ₱10,000; facility/bench/safety materials up to ₱15,000 only if allowed; reporting/confirmatory tests up to ₱6,000 only if allowed. Re-map to the signed budget; never spend or reallocate based only on this estimate. | DOST-TAPI/project officer, qualified lab, suppliers and research institutions (all subject to grant/procurement rules). | Grant agreement, approved line-item budget, statement of expenses, supporting documents, protocol, quotes, purchase approvals, batch/QC logs and final report. |
| 2. Operational Efficiency & Productivity Supply + portfolio scope | Stabilize botanical raw materials; defer capital-intensive microbial production and new-source formulation until funded. | Q1: Map Tagetes supply, supplier locations, seasonal availability, lot variability and price per usable unit. Q2: Define incoming material specifications and rejection rules. Q3: Conduct only partner-funded or approved small screening of one alternative botanical (e.g. citronella) if GolBi deliverables are on track. Q4: No microbial equipment purchase or new product launch unless fully financed and tied to a validated business case. | Supplier mapping Q1; specs Q2; optional gated screen Q3; decision Q4. | ₱0 additional capital in base case for microbial machines and alternative-botanical development. Use desk research and current supplier quotes; new experiments only from specifically eligible funds or confirmed partner funding. | Botanical growers, raw-material aggregators, qualified labs/universities, DOST and research collaborators. | Supplier quotes, seasonal calendar, raw-material QC sheet, cost per usable input, alternative source literature, partner scope and funding confirmation. |
| 3. Organizational Strengthening One accountable owner | Separate responsibilities and cost centres so three ventures do not blur cash, time and accountability. | Q4 2026: Create distinct ledgers for TerraSync, PAGBI, and GolBi/DOST-TAPI; assign an accountable owner for every deliverable. Q1: Run a 30-minute weekly operations/cash review and monthly close. Q2: Adopt SOPs for quoting, deposits, SKU purchasing, stock counts, batch records, grant procurement and customer follow-up. Q3: Formalize collaborations only with a named deliverable, owner and written work plan. Q4: Assess founder bottlenecks and fund new roles only from recurring revenue/committed funding. | Set up by Q1; weekly/ monthly controls; quarterly review. | ₱0 new payroll in base case. Use existing software, spreadsheets and partner expertise. Any paid bookkeeping/training must be quoted and approved against unrestricted funds first. | Founder/management, bookkeeper/accountant, DOST-TAPI, university or technical mentors, cooperative/industry partners. | RACI matrix, cost-centre ledger, KPI owner list, SOP checklist, meeting notes, service terms and partner MoUs/work plans. |
| 4. Financial Health Cash survival | Know the real unrestricted cash position and prevent cross-subsidizing one venture with another’s restricted funds. | Within 10 working days: Reconcile bank/cash, ₱70,000 reported grant use, receipts, commitments and the true uncommitted grant balance. Q1: Build a rolling 13-week cash forecast and simple profit/loss by unit. Q2: Review aged payables/receivables, stock age, contribution margin and monthly break-even. Q3: Seek only milestone-linked grants, co-testing, pre-orders or strategic collaborations. Q4: Prepare 2028 financing plan from actual collections, cost data and validated milestones. | Cash forecast weekly; monthly close by 5th working day; quarterly finance review. | ₱0 planned new debt and ₱0 speculative capex. Use current spreadsheets first. Grant funds, PAGBI stock capital and unrestricted cash remain separate. Keep a proposed minimum 8 weeks fixed-cost coverage before optional spend; if below 4 weeks, activate survival mode. | Grant officer, bookkeeper/accountant, suppliers, customers, eligible grant programmes, technical/institutional partners. | Bank reconciliation, 13-week cash forecast, cost sheet, grant ledger, aged payables/receivables, monthly P&L, reorder controls and price log. |
Decision rule: no activity is “funded” until it has an approved source, a current quote, an owner and a documented success criterion. Grant line items and regulatory requirements override this management proposal.
Budget control
Protect the envelopes. Do not confuse budget with cash.
Budget allocation is conditional until reconciled against bank balances, purchase commitments, grant rules and the final permit costs.
| Envelope / purpose | Known amount | Immediate release | Hold / restriction | Release trigger |
|---|---|---|---|---|
| DOST-TAPI GolBi validation | ₱158,000 award; ~₱70,000 reportedly used; ₱88,000 arithmetic difference before reconciliation. | Only for verified, grant-eligible items already approved by the signed work plan. | No general working capital, unrelated PAGBI inventory, microbial equipment or building costs unless explicitly allowed. No changes to budget lines without required written approval. | Receipts/commitments reconciled; project officer/procurement requirements confirmed; quote and milestone match approved budget. |
| PAGBI retail | ₱120,000 planned stock envelope; ₱6,000 licensing reserve described separately (confirm whether inside/outside the stock envelope). | First order capped at ₱30,000 after required permits, valid supplier documentation and SKU margin sheet. | Hold remaining stock capital; don’t buy the whole plan at launch. If the ₱6,000 fee is inside ₱120,000, total stock ceiling is ₱114,000 before other costs. | Licences/permits confirmed, current quotes compared, minimum margin set, demand evidenced and cash forecast remains viable. |
| TerraSync services | ₱0 new capital assumed. | Up to ₱3,000 outreach/delivery spend only from received client deposits/collections. | No paid advertising and no recurring software commitments until collected revenue covers them. | Signed scope, advance deposit, profitable delivery estimate and clear collection date. |
| Building completion | Cost not yet supplied; do not invent a total. | Only items on a written punch list and confirmed quote with identified source of funds. | No spend from the TAPI award unless the exact cost is grant-eligible and approved. | Contractor cost-to-complete, lawful funding source, required approvals/inspections and receipts. |
| Microbial machines / new botanicals | ₱0 in the 2027 base case. | No capital release. | R&D is paused; use literature, supplier mapping and partner conversations only. | 100% dedicated funding, an approved technical plan, safety/space readiness and a market/use-case decision. |
Strict interpretation: the ₱88,000 grant difference is not an available operating-cash balance; the ₱120,000 PAGBI amount is a planned stock envelope; and the building completion cost remains unknown. Do not add these into one “cash available” number.
Key Performance Indicators
Track outputs (what we did) and outcomes (what changed).
These are proposed targets for management review, not established historical performance. Adjust after the first 30–60 days of actual baseline data.
1. Market readiness and sales
Outcome indicators
Cash collected by business unitTrack monthly collected revenue—not quotes, pipeline value or unpaid invoices. Separate TerraSync, PAGBI and grants.Monthly
Repeat demand and customer retentionBy Q4, aim for at least 2 TerraSync clients on repeat work/maintenance; record repeat purchase rate once PAGBI is permitted.Quarterly
Output indicators
TerraSync prospect-to-cash funnelQ1 target: 10 qualified prospects and at least 2 paid pilot projects. Track leads, proposals, deposits, delivery time and project contribution margin.Weekly
Active sales channelsBy Q4, pursue 2 tested channels (e.g. direct B2B and partner referrals), only expanding after lead conversion is measured.Quarterly
2. Operational efficiency and compliance
Outcome indicators
Batch reproducibilityTarget 3 independently prepared batches assessed against predefined acceptance criteria, provided these fit the approved protocol and budget.At validation milestones
Safe, compliant activityZero sales/repacking activity outside the applicable licence/product authorization; verify written permit status before launching relevant activity.Before each activity
Output indicators
Grant-funded deliverables and records100% of scheduled eligible grant deliverables completed or explained by agreed deadlines; 100% of expenses have the required supporting documentation.Monthly / grant schedule
Stock and supplier controls100% of PAGBI SKUs have supplier invoice, current landed cost, expiry/lot record and price/margin calculation; maintain 3 quotes for material categories where feasible.Every purchase / weekly stock count
3. Organization and systems
Outcome indicators
Accountability100% of strategic KPIs have an owner, current status, next action and evidence link.Monthly
Decision speedHold one monthly close and one quarterly review; unresolved critical issues have a named owner and deadline.Monthly / quarterly
Output indicators
Separate ledgersMaintain distinct cost centres and bank/ledger classifications for TerraSync, PAGBI and PHYTOSPHERE R&D/TAPI.Every transaction
Operating proceduresCore SOPs for quoting/deposits, inventory, grant procurement, batch records and monthly finance review established by Q2.Q2 checkpoint
4. Financial health
Outcome indicators
Contribution marginPositive contribution after direct labour/time, freight, payment fees, packaging, discounts and other variable costs for each TerraSync offer and PAGBI SKU. Do not assume retail revenue means profit.Every project/SKU; monthly review
Cash disciplineQ4 target: two consecutive months where collected non-grant operating contribution covers routine operating outflow. If not achieved, activate a written survival plan and freeze discretionary spending.Monthly
Output indicators
Cash forecast and closing accountsUpdate the next 13 weeks every week; complete month-end close by the 5th working day; report weeks of cash coverage and overdue payables.Weekly / monthly
Funding readinessBy Q4, prepare a 2028 financing case with verified costs, milestones, sales evidence and funding requirements; pursue at least 2 suitable support opportunities only when eligible.Quarterly
Control thresholds
Every KPI needs a response when it misses.
Proposed management targets, not industry benchmarks. Validate after the first 30–60 days of actual data.
| Metric | Target / trigger | Review | What to do if missed |
|---|---|---|---|
| 13-week cash forecast | Updated weekly; all known bills and confirmed receipts included. | Every Monday | If less than 8 weeks of fixed costs are covered after planned spend, freeze optional spending. If under 4 weeks, stop nonessential procurement, collect receivables, negotiate payables early and create a survival budget. |
| TAPI grant reconciliation | 100% of reported spending matched to approved line items and supporting documents before the next grant-related purchase. | Now, then monthly | Pause non-urgent grant procurement; reconcile receipts and commitments; ask the project officer in writing about variances before reallocating. |
| TerraSync paid validation | At least 2 paid pilot jobs by end of Q1; seek an advance deposit of at least 50% for custom work where commercially appropriate. | Weekly pipeline | After 30 qualified prospect contacts without a paid pilot, narrow the offer, revise the value proposition/price and interview lost prospects. Do not respond by buying ads or adding software. |
| TerraSync contribution | Positive contribution per project after direct labor/time, tools, fees, hosting and revisions. | After every job; monthly | Increase price, narrow scope, reduce revisions, require milestone payments or stop offering the unprofitable package. |
| PAGBI launch authorization | 100% of the required local permits/FPA authorizations verified before the applicable sales, handling or repacking activity. | Before opening / activity | Do not launch that activity; keep stock orders on hold where appropriate; ask the relevant agency for written clarification. |
| PAGBI first inventory tranche | Initial order ≤₱30,000; aim for at least 60% sell-through in 60–90 days. Proposed internal gate, not an industry standard. | Weekly counts; monthly sell-through | No replenishment if sell-through is below threshold. Review SKU selection, price, location, seasonality and supplier terms; do not increase capital committed. |
| PAGBI SKU margin | Every SKU has current landed cost, expiry/lot record and realised margin. Proposed minimum gate: 15% gross margin after direct landed cost, adjusted by category economics. | Before order and monthly | If margin is below the approved floor, renegotiate, reprice where customers accept it, select another SKU or stop stocking it. Requote before purchasing. |
| GolBi validation milestones | 100% of scheduled grant deliverables completed or formally explained; batches/tests meet written acceptance criteria. | Per protocol / monthly | Document failure and root cause. Repeat only when approved and funded. Do not claim proven efficacy or sell without applicable authorization. |
| Microbial R&D spending | ₱0 machine/equipment capital in base plan until dedicated funding and market/technical case are documented. | Quarterly | Defer purchase. Pursue in-kind access, university/lab partnership, or a dedicated grant only if the project does not threaten cash survival. |
| Supplier price volatility | Current quote for every important reorder; 3 quotes where feasible; reconfirm quotes older than 7 days. | Before each purchase | Recalculate landed cost and margin; delay discretionary buys if cost changed materially or customer prices cannot absorb the increase. |
KPI rule: record a baseline before reporting improvement. Count cash received, not expected revenue; count registered/licensed status only from official evidence; count test results only from documented protocols and reports.
The 2027 sequence
Do the work in the order that reduces risk.
Quarterly plans can change with permits, grant deadlines, supplier prices and customer response. Review each quarter as a decision gate, not a promise to scale.
Secure the basics
- Confirm local permits and FPA status applicable to each activity.
- Close grant reconciliation and use approved work plan as the test schedule.
- Launch TerraSync offers and collect first paid projects/deposits.
- Hold weekly 13-week cash reviews.
Output: clean cash baseline, paid pilot activity, compliant launch gates.
Prove the economics
- Evaluate GolBi validation results and batch records.
- Test actual time, price and contribution margin for TerraSync work.
- Start PAGBI only after permits; stock a narrow, quote-checked mix.
- Review inventory age and cash collections monthly.
Output: first reliable unit-economics and product-validation evidence.
Standardize what works
- Improve SOPs based on deviations and customer feedback.
- Seek repeat service contracts and supplier terms.
- Only test wider distribution when replenishment and margins work.
- Seek funding partners around specific gaps, not broad ideas.
Output: lower delivery variability and repeatable cash-generating workflows.
Make a scale decision
- Review cash flow, client repeat work, stock sell-through and payables.
- Determine whether GolBi has the evidence and approvals for its next stage.
- Hold microbial capital expenditure unless separately funded.
- Write the 2028 investment case and downside plan.
Output: evidence-led go / pause / stop decision and 2028 plan.
Rules to scale
Five gates must pass before PHYTOSPHERE commits to a bigger operation.
01
Authorization
Required local business permits, applicable FPA licences and product-specific authorizations are documented for the exact activity.
02
Product consistency
Testing is completed, batch criteria are met and the evidence package is complete. No marketing promise should exceed the evidence.
03
Customer proof
At least repeat purchase or validated willingness to pay—not only awards, likes, interest or unpaid demos.
04
Positive economics
Every product/service has its fully loaded cost, contribution margin, fulfillment cost and working-capital cycle understood.
05
Cash resilience
No scale-up capex unless the rolling forecast covers committed costs and leaves a proposed minimum eight weeks of fixed-cost coverage after the spend.
!
Fail a gate? Pause.
Freeze discretionary purchases, focus on TerraSync cash collections and permitted PAGBI sales, complete grant obligations, and re-test the plan.
The proposed eight-week cash coverage is an internal management guardrail, not a legal or industry standard. Adapt it after calculating actual weekly fixed costs.
Reference links
Sources to check as the plan changes.
Market conditions, price references and official application requirements change. The links below support the planning assumptions and should be checked again before purchasing, licensing or expanding.
Before financial decisions: use the signed DOST-TAPI grant agreement, actual bank records, receipts, open purchase orders and official FPA/municipal responses as the controlling records. This plan is a management aid, not a replacement for your accountant, grant officer or regulator.